Chembio Diagnostics (Chembio Diagnostics) Net Income Including Noncontrolling Interests : $-23.29 Mil (TTM As of Dec. 2022)

View and export this data going back to 2004. Start your Free Trial

What is Chembio Diagnostics Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Chembio Diagnostics's Net Income Including Noncontrolling Interests for the three months ended in Dec. 2022 was $-0.86 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2022 was $-23.29 Mil.

Chembio Diagnostics Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Chembio Diagnostics's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chembio Diagnostics Net Income Including Noncontrolling Interests Chart

Chembio Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Net Income Including Noncontrolling Interests

Get a 7-Day Free Trial

-7.87

-13.68

-25.52

-33.90

-23.29

Chembio Diagnostics Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Net Income Including Noncontrolling Interests	Get a 7-Day Free Trial															-13.97	-8.79	-6.95	-6.70	-0.86

Chembio Diagnostics Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-23.29 Mil.

Chembio Diagnostics Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Chembio Diagnostics's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Chembio Diagnostics (Chembio Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Chembio Diagnostics Inc (NAS:CEMI) » Definitions » Net Income Including Noncontrolling Interests

Comparable Companies

Traded in Other Exchanges

N/A

Address

3661 Horseblock Road, Medford, NY, USA, 11763

Website

http://www.chembio.com

Chembio Diagnostics Inc is a company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.

Executives

Perceptive Credit Advisors, Llc	10 percent owner	51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Joseph Edelman	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Advisors Llc	10 percent owner	51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Leslie Teso-lichtman	director	C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
Charles Caso	officer: See remarks	C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
Paul Angelico	officer: See remarks	C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
Lawrence J. Steenvoorden	officer: See remarks	C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
David William Bespalko	director	29 CEDAR DRIVE, ALLENDALE NJ 07401
David Acheson	director	C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
Richard Eberly	officer: See Remarks	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
John Gary Potthoff	director	6140 SPANISH OAKS CLUB BLVD., AUSTIN TX 78738
Javan Esfandiari	officer: Senior Vice President	3661 HORSEBLOCK ROAD, MEDFORD NY 11763
Robert Passas	officer: See Remarks	3661 HORSEBLOCK ROAD, MEDFORD NY 11763
Polan Mary Lake Ph D	director	STANFORD UNIVERSITY SCHOOL OF MEDICINE, 300 PASTAUR DR ROOM HH333, STANFORD CA 94305-5317
Neil A Goldman	officer: Executive VP and CFO	3661 HORSEBLOCK RD, MEDFORD NY 11763